I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 34% ± 25% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 34% ± 25% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 6633.24 | 2399 / 2642 | 91% | 14.53 | 639 / 705 |
| adrenal gland | 55% | 435.64 | 143 / 258 | 84% | 11.12 | 194 / 230 |
| thymus | 23% | 147.12 | 150 / 653 | 68% | 3.83 | 409 / 605 |
| kidney | 72% | 516.45 | 64 / 89 | 16% | 1.22 | 143 / 901 |
| ovary | 0% | 0 | 0 / 180 | 68% | 8.24 | 294 / 430 |
| uterus | 16% | 131.67 | 27 / 170 | 34% | 5.60 | 158 / 459 |
| peripheral blood | 44% | 797.19 | 413 / 929 | 0% | 0 | 0 / 0 |
| lung | 16% | 127.95 | 95 / 578 | 16% | 1.23 | 181 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 0.94 | 8 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 2.85 | 12 / 45 |
| spleen | 24% | 161.76 | 57 / 241 | 0% | 0 | 0 / 0 |
| breast | 10% | 58.63 | 48 / 459 | 10% | 0.55 | 109 / 1118 |
| pancreas | 3% | 16.02 | 11 / 328 | 16% | 1.75 | 28 / 178 |
| skin | 0% | 1.19 | 3 / 1809 | 17% | 0.85 | 80 / 472 |
| esophagus | 1% | 3.04 | 8 / 1445 | 14% | 0.68 | 25 / 183 |
| liver | 0% | 0 | 0 / 226 | 13% | 1.95 | 51 / 406 |
| stomach | 0% | 2.08 | 1 / 359 | 12% | 1.31 | 34 / 286 |
| prostate | 8% | 38.41 | 19 / 245 | 4% | 0.17 | 22 / 502 |
| bladder | 0% | 0 | 0 / 21 | 7% | 0.61 | 34 / 504 |
| intestine | 0% | 1.32 | 3 / 966 | 6% | 0.52 | 31 / 527 |
| heart | 0% | 1.82 | 3 / 861 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.74 | 2 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.82 | 2 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.82 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006813 | Biological process | potassium ion transport |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005249 | Molecular function | voltage-gated potassium channel activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCNH3 |
| Protein name | Potassium voltage-gated channel subfamily H member 3 Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1) (BEC1) (Ether-a-go-go-like potassium channel 2) (ELK channel 2) (ELK2) (Voltage-gated potassium channel subunit Kv12.2) Potassium voltage-gated channel, subfamily H (Eag-related), member 3 |
| Synonyms | KIAA1282 |
| Description | FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium channel. Elicits an outward current with fast inactivation. Channel properties may be modulated by cAMP and subunit assembly. |
| Accessions | ENST00000649994.1 Q9ULD8 A0A3B3ITH0 B9EK44 ENST00000257981.7 |
